U of T Startup Targets Harmful Side Effect of Cancer Treatment

By
Noshin Noorjahan
-
0
14
HDAX Therapeutics is focused on developing treatments for peripheral nerve damage, which can result from chemotherapy or radiation.
[University of Toronto]
Press Release